Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruottinen, H. M.
Right arrow Articles by Rinne, J. O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruottinen, H. M.
Right arrow Articles by Rinne, J. O.
Neurology 2000;54:502
© 2000 American Academy of Neurology


Brief Communications

An FDOPA PET study in patients with periodic limb movement disorder and restless legs syndrome

H. M. Ruottinen, MD, PhD, M. Partinen, MD, PhD, C. Hublin, MD, PhD, J. Bergman, MSc, M. Haaparanta, MSc, O. Solin, PhD and J. O. Rinne, MD, PhD

From the Department of Neurology (Drs. Ruottinen and Rinne), University of Turku; Haaga Neurological Research Centre (Drs. Partinen and Hublin), Helsinki; and Turku PET Centre (J. Bergman, M. Haaparanta, and Drs. Solin and Rinne), Turku, Finland.

Address correspondence and reprint requests to Dr. Hanna M. Ruottinen, Department of Neurology, University of Turku, FIN-20520 Turku, Finland.

The authors investigated nine drug-naïve patients with periodic limb movement disorder and restless legs syndrome (PLMD-RLS) and 27 healthy controls with PET using 6-[18F]fluoro-L-dopa (FDOPA). In the patients, the FDOPA uptake (Kiocc) in the caudate nucleus was 88% and in the putamen 89% of the control mean values. This equal affection of the caudate and the putamen differs, for example, from the dopaminergic dysfunction in Parkinson’s disease, which affects the putamen earlier and more severely than the caudate. The current results indicate mild nigrostriatal presynaptic dopaminergic hypofunction in PLMD-RLS.

Key words: Dopamine—FDOPA PET—Periodic limb movement disorder—Restless legs syndrome




This article has been cited by other articles:


Home page
J PsychopharmacolHome page
S.-G. Kang, H.-J. Lee, and L. Kim
Restless legs syndrome and periodic limb movements during sleep probably associated with olanzapine
J Psychopharmacol, July 1, 2009; 23(5): 597 - 601.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
F M Skidmore, V. Drago, P S Foster, and K M Heilman
Bilateral restless legs affecting a phantom limb, treated with dopamine agonists
J. Neurol. Neurosurg. Psychiatry, May 1, 2009; 80(5): 569 - 570.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
O. C. Molokwu
Appropriate Use of Dopamine Agonists and Levodopa in Restless Legs Syndrome in an Ambulatory Care Setting
Ann. Pharmacother., May 1, 2008; 42(5): 627 - 632.
[Abstract] [Full Text] [PDF]


Home page
CLIN PEDIATRHome page
A. L. Starn and J. N. Udall JR
Iron Deficiency Anemia, Pica, and Restless Legs Syndrome in a Teenage Girl
Clinical Pediatrics, February 1, 2008; 47(1): 83 - 85.
[PDF]


Home page
Journal of Pharmacy PracticeHome page
M. Ryan and J. T. Slevin
Restless Legs Syndrome
Journal of Pharmacy Practice, December 1, 2007; 20(6): 430 - 448.
[Abstract] [PDF]


Home page
Am J Health Syst PharmHome page
M. Ryan and J. T. Slevin
Restless legs syndrome.
Am. J. Health Syst. Pharm., September 1, 2006; 63(17): 1599 - 1612.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. Cervenka, S. E. Palhagen, R. A. Comley, G. Panagiotidis, Z. Cselenyi, J. C. Matthews, R. Y. Lai, C. Halldin, and L. Farde
Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding
Brain, August 1, 2006; 129(8): 2017 - 2028.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
B. Phillips, W. Hening, P. Britz, and D. Mannino
Prevalence and Correlates of Restless Legs Syndrome: Results From the 2005 National Sleep Foundation Poll
Chest, January 1, 2006; 129(1): 76 - 80.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
R. K. Bogan, J. M. Fry, M. H. Schmidt, S. W. Carson, S. Y. Ritchie, and TREAT RLS US (Therapy with Ropinirole Efficacy And
Ropinirole in the Treatment of Patients With Restless Legs Syndrome: A US-Based Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Mayo Clin. Proc., January 1, 2006; 81(1): 17 - 27.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. H. Adler and M. J. Thorpy
Sleep issues in Parkinson's disease
Neurology, June 28, 2005; 64(12_suppl_3): S12 - S20.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. J. Thorpy
New paradigms in the treatment of restless legs syndrome
Neurology, June 28, 2005; 64(12_suppl_3): S28 - S33.
[Abstract] [Full Text] [PDF]


Home page
BrainHome page
S. von Spiczak, A. L. Whone, A. Hammers, M.-C. Asselin, F. Turkheimer, T. Tings, S. Happe, W. Paulus, C. Trenkwalder, and D. J. Brooks
The role of opioids in restless legs syndrome: an [11C]diprenorphine PET study
Brain, April 1, 2005; 128(4): 906 - 917.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
G G Tribl, T Sycha, N Kotzailias, J Zeitlhofer, and E Auff
Apomorphine in idiopathic restless legs syndrome: an exploratory study
J. Neurol. Neurosurg. Psychiatry, February 1, 2005; 76(2): 181 - 185.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
W. Poewe and B. Hogl
Akathisia, restless legs and periodic limb movements in sleep in Parkinson's disease
Neurology, October 26, 2004; 63(8_suppl_3): S12 - S16.
[Abstract] [Full Text]


Home page
NeurologyHome page
B. Phillips
Movement disorders: A sleep specialist's perspective
Neurology, March 9, 2004; 62(90052): S9 - 16.
[Abstract] [Full Text]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Sevim, O Dogu, H Kaleagasi, M Aral, O Metin, and H Camdeviren
Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 226 - 230.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
D. Garcia-Borreguero, P. Odin, and C. Serrano
Restless legs syndrome and PD: A review of the evidence for a possible association
Neurology, September 23, 2003; 61(90063): S49 - 55.
[Abstract] [Full Text]


Home page
NeurologyHome page
A. Desautels, G. Turecki, J. Montplaisir, K. Brisebois, A. Sequeira, B. Adam, and G. A. Rouleau
Evidence for a genetic association between monoamine oxidase A and restless legs syndrome
Neurology, July 23, 2002; 59(2): 215 - 219.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
W. G. Ondo, K. D. Vuong, and J. Jankovic
Exploring the Relationship Between Parkinson Disease and Restless Legs Syndrome
Arch Neurol, March 1, 2002; 59(3): 421 - 424.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. L. Comella
Restless legs syndrome: Treatment with dopaminergic agents
Neurology, February 1, 2002; 58(90001): S87 - 92.
[Abstract] [Full Text]


Home page
NeurologyHome page
I. Eisensehr, T. C. Wetter, R. Linke, S. Noachtar, H. v. Lindeiner, F. J. Gildehaus, C. Trenkwalder, and K. Tatsch
Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome
Neurology, October 9, 2001; 57(7): 1307 - 1309.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
K R. CHAUDHURI, L S APPIAH-KUBI, and C TRENKWALDER
Restless legs syndrome
J. Neurol. Neurosurg. Psychiatry, August 1, 2001; 71(2): 143 - 146.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by AAN Enterprises, Inc.